Clinical trial
Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in…
NCT00202787 · Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD), Other · Completed
Key facts
| NCT number | NCT00202787 |
|---|---|
| Title | Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer |
| Official title | Open-label, Phase II, Randomised, Pilot Study to Evaluate the Safety and Efficacy of Combination Therapy With Cetuximab and FOLFOX4 or FOLFOX4 Alone in Patients Colorectal Cancer and Initially Non-resectable |
| Lead sponsor | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD), Other |
| Collaborators | Merck Sharp & Dohme LLC Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | FOLFOX-4+cetuximab, FOLFOX-4 |
| Enrollment | 136 |
| Start date | Feb 1, 2005 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Sep 20, 2005 |
| Last update posted | Feb 20, 2013 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: